Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Veterans | 28 | 2024 | 560 | 3.530 |
Why?
|
| Analgesics, Opioid | 18 | 2024 | 557 | 2.870 |
Why?
|
| Chronic Pain | 8 | 2021 | 166 | 2.280 |
Why?
|
| United States Department of Veterans Affairs | 18 | 2024 | 288 | 2.010 |
Why?
|
| Antipsychotic Agents | 11 | 2018 | 232 | 1.820 |
Why?
|
| Mental Health Services | 6 | 2020 | 199 | 1.540 |
Why?
|
| Stress Disorders, Post-Traumatic | 11 | 2019 | 365 | 1.290 |
Why?
|
| Rural Health Services | 5 | 2018 | 164 | 1.270 |
Why?
|
| Opioid-Related Disorders | 8 | 2024 | 384 | 1.230 |
Why?
|
| United States | 40 | 2024 | 4874 | 1.120 |
Why?
|
| Telemedicine | 7 | 2019 | 449 | 1.060 |
Why?
|
| Schizophrenia | 10 | 2009 | 256 | 1.040 |
Why?
|
| Depressive Disorder | 3 | 2018 | 339 | 1.000 |
Why?
|
| Patient Satisfaction | 3 | 2021 | 275 | 0.990 |
Why?
|
| Patient Acceptance of Health Care | 5 | 2019 | 328 | 0.930 |
Why?
|
| Primary Health Care | 5 | 2019 | 360 | 0.880 |
Why?
|
| Quality Indicators, Health Care | 4 | 2017 | 86 | 0.870 |
Why?
|
| Mental Disorders | 6 | 2020 | 395 | 0.860 |
Why?
|
| Substance-Related Disorders | 6 | 2021 | 601 | 0.850 |
Why?
|
| Afghan Campaign 2001- | 3 | 2018 | 40 | 0.850 |
Why?
|
| Depression | 4 | 2020 | 570 | 0.780 |
Why?
|
| Middle Aged | 39 | 2024 | 12206 | 0.740 |
Why?
|
| Veterans Health | 3 | 2014 | 62 | 0.700 |
Why?
|
| Adult | 36 | 2024 | 13324 | 0.700 |
Why?
|
| Male | 46 | 2024 | 25399 | 0.680 |
Why?
|
| Psychotherapy | 5 | 2019 | 106 | 0.680 |
Why?
|
| Cooperative Behavior | 4 | 2015 | 227 | 0.660 |
Why?
|
| Ambulatory Care Facilities | 3 | 2018 | 125 | 0.640 |
Why?
|
| Community Health Centers | 2 | 2018 | 30 | 0.630 |
Why?
|
| Drug Utilization | 3 | 2017 | 77 | 0.630 |
Why?
|
| Hospitals, Veterans | 6 | 2014 | 110 | 0.630 |
Why?
|
| Humans | 66 | 2024 | 50208 | 0.620 |
Why?
|
| Female | 44 | 2024 | 26635 | 0.610 |
Why?
|
| Developmental Disabilities | 1 | 2019 | 119 | 0.610 |
Why?
|
| Health Services Needs and Demand | 1 | 2019 | 158 | 0.590 |
Why?
|
| Buprenorphine | 3 | 2024 | 139 | 0.590 |
Why?
|
| Aged | 28 | 2021 | 9405 | 0.580 |
Why?
|
| Inappropriate Prescribing | 1 | 2017 | 18 | 0.570 |
Why?
|
| Medicaid | 8 | 2021 | 257 | 0.570 |
Why?
|
| Off-Label Use | 1 | 2017 | 25 | 0.570 |
Why?
|
| Aftercare | 1 | 2017 | 75 | 0.560 |
Why?
|
| Drug Overdose | 4 | 2022 | 163 | 0.520 |
Why?
|
| Healthcare Disparities | 1 | 2019 | 268 | 0.520 |
Why?
|
| Alcoholism | 4 | 2021 | 233 | 0.510 |
Why?
|
| Pain | 4 | 2021 | 381 | 0.500 |
Why?
|
| Hospitalization | 3 | 2017 | 655 | 0.500 |
Why?
|
| Opiate Substitution Treatment | 3 | 2024 | 88 | 0.490 |
Why?
|
| Urban Health Services | 1 | 2014 | 21 | 0.480 |
Why?
|
| Antidepressive Agents | 2 | 2014 | 176 | 0.470 |
Why?
|
| Prescription Drugs | 1 | 2014 | 38 | 0.470 |
Why?
|
| Patient Compliance | 3 | 2009 | 230 | 0.420 |
Why?
|
| Drug Prescriptions | 4 | 2018 | 97 | 0.410 |
Why?
|
| Health Services Accessibility | 5 | 2020 | 399 | 0.410 |
Why?
|
| Prevalence | 7 | 2020 | 951 | 0.380 |
Why?
|
| Retrospective Studies | 17 | 2024 | 6134 | 0.380 |
Why?
|
| Adolescent | 15 | 2020 | 6390 | 0.370 |
Why?
|
| Young Adult | 12 | 2020 | 3981 | 0.350 |
Why?
|
| Aged, 80 and over | 9 | 2019 | 3154 | 0.330 |
Why?
|
| Drug Utilization Review | 1 | 2008 | 23 | 0.320 |
Why?
|
| Data Collection | 3 | 2008 | 277 | 0.310 |
Why?
|
| Biomedical Research | 3 | 2018 | 236 | 0.310 |
Why?
|
| Mental Health | 2 | 2020 | 220 | 0.310 |
Why?
|
| Pain Measurement | 3 | 2021 | 240 | 0.290 |
Why?
|
| Patient Care Team | 4 | 2015 | 257 | 0.290 |
Why?
|
| Patient Education as Topic | 2 | 2008 | 313 | 0.290 |
Why?
|
| Patient-Centered Care | 1 | 2008 | 131 | 0.270 |
Why?
|
| Pandemics | 2 | 2021 | 562 | 0.260 |
Why?
|
| Homes for the Aged | 1 | 2005 | 33 | 0.250 |
Why?
|
| Health Promotion | 1 | 2008 | 267 | 0.250 |
Why?
|
| Rural Population | 3 | 2019 | 537 | 0.240 |
Why?
|
| Nursing Homes | 1 | 2005 | 114 | 0.240 |
Why?
|
| Psychotic Disorders | 1 | 2005 | 133 | 0.230 |
Why?
|
| Treatment Refusal | 1 | 2004 | 37 | 0.230 |
Why?
|
| Schizophrenic Psychology | 1 | 2004 | 68 | 0.230 |
Why?
|
| Cross-Sectional Studies | 5 | 2021 | 1554 | 0.220 |
Why?
|
| Pirenzepine | 1 | 2003 | 4 | 0.220 |
Why?
|
| Drug Costs | 1 | 2003 | 39 | 0.210 |
Why?
|
| Risk Factors | 6 | 2020 | 3629 | 0.210 |
Why?
|
| Emergency Service, Hospital | 2 | 2018 | 484 | 0.210 |
Why?
|
| Arkansas | 8 | 2021 | 1985 | 0.200 |
Why?
|
| Logistic Models | 7 | 2018 | 889 | 0.200 |
Why?
|
| Benzodiazepines | 2 | 2018 | 73 | 0.200 |
Why?
|
| Suicide | 1 | 2023 | 76 | 0.200 |
Why?
|
| Comorbidity | 3 | 2017 | 613 | 0.190 |
Why?
|
| Wounds and Injuries | 3 | 2019 | 281 | 0.180 |
Why?
|
| Follow-Up Studies | 5 | 2021 | 2190 | 0.180 |
Why?
|
| Patient Protection and Affordable Care Act | 1 | 2021 | 50 | 0.180 |
Why?
|
| Practice Guidelines as Topic | 5 | 2008 | 449 | 0.180 |
Why?
|
| Social Media | 1 | 2022 | 96 | 0.170 |
Why?
|
| Age Distribution | 3 | 2018 | 168 | 0.170 |
Why?
|
| Depressive Disorder, Major | 2 | 2020 | 151 | 0.170 |
Why?
|
| Cerebrovascular Disorders | 1 | 2019 | 55 | 0.170 |
Why?
|
| Cost-Benefit Analysis | 2 | 2015 | 273 | 0.160 |
Why?
|
| Myocardial Ischemia | 1 | 2019 | 121 | 0.150 |
Why?
|
| Medication Adherence | 2 | 2009 | 130 | 0.150 |
Why?
|
| Urban Population | 1 | 2019 | 150 | 0.150 |
Why?
|
| Purinergic P2Y Receptor Antagonists | 1 | 2018 | 29 | 0.150 |
Why?
|
| Mentors | 1 | 2018 | 55 | 0.150 |
Why?
|
| Pharmacoepidemiology | 1 | 2017 | 8 | 0.150 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 169 | 0.150 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 178 | 0.140 |
Why?
|
| Program Development | 1 | 2018 | 167 | 0.140 |
Why?
|
| Standard of Care | 1 | 2017 | 16 | 0.140 |
Why?
|
| Universities | 1 | 2018 | 162 | 0.140 |
Why?
|
| Ambulatory Care | 1 | 2018 | 222 | 0.140 |
Why?
|
| Cohort Studies | 5 | 2020 | 1422 | 0.140 |
Why?
|
| Safety-Based Drug Withdrawals | 1 | 2015 | 7 | 0.130 |
Why?
|
| Dextropropoxyphene | 1 | 2015 | 6 | 0.130 |
Why?
|
| Chronic Disease | 4 | 2018 | 571 | 0.130 |
Why?
|
| Proportional Hazards Models | 2 | 2014 | 410 | 0.130 |
Why?
|
| Odds Ratio | 3 | 2020 | 546 | 0.120 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2018 | 169 | 0.120 |
Why?
|
| Curriculum | 1 | 2018 | 400 | 0.120 |
Why?
|
| Thrombosis | 1 | 2018 | 248 | 0.120 |
Why?
|
| Health Care Costs | 3 | 2015 | 170 | 0.120 |
Why?
|
| Health Services | 2 | 2020 | 67 | 0.120 |
Why?
|
| Longitudinal Studies | 2 | 2014 | 695 | 0.120 |
Why?
|
| Social Networking | 1 | 2014 | 15 | 0.120 |
Why?
|
| Risk Assessment | 2 | 2008 | 1262 | 0.110 |
Why?
|
| Insurance, Health | 2 | 2021 | 125 | 0.110 |
Why?
|
| Social Support | 1 | 2014 | 264 | 0.110 |
Why?
|
| Monitoring, Physiologic | 1 | 2013 | 120 | 0.110 |
Why?
|
| Psychiatric Status Rating Scales | 3 | 2015 | 319 | 0.110 |
Why?
|
| Survival Analysis | 1 | 2014 | 666 | 0.110 |
Why?
|
| Insurance Claim Review | 2 | 2009 | 36 | 0.110 |
Why?
|
| Software | 1 | 2014 | 271 | 0.100 |
Why?
|
| Sex Factors | 1 | 2014 | 697 | 0.100 |
Why?
|
| Insurance Claim Reporting | 2 | 2009 | 11 | 0.090 |
Why?
|
| Child, Preschool | 1 | 2019 | 3883 | 0.090 |
Why?
|
| Guideline Adherence | 2 | 2008 | 133 | 0.080 |
Why?
|
| Bipolar Disorder | 2 | 2008 | 192 | 0.080 |
Why?
|
| Cognition Disorders | 1 | 2011 | 215 | 0.080 |
Why?
|
| Anxiety | 2 | 2021 | 275 | 0.080 |
Why?
|
| Dementia | 1 | 2010 | 143 | 0.080 |
Why?
|
| Role Playing | 1 | 2008 | 3 | 0.080 |
Why?
|
| Cognition | 1 | 2011 | 335 | 0.080 |
Why?
|
| Treatment Outcome | 5 | 2020 | 5155 | 0.070 |
Why?
|
| Quality Assurance, Health Care | 1 | 2008 | 149 | 0.070 |
Why?
|
| Delivery of Health Care | 2 | 2021 | 310 | 0.070 |
Why?
|
| Hypoglycemic Agents | 1 | 2008 | 168 | 0.070 |
Why?
|
| Child | 1 | 2019 | 6851 | 0.070 |
Why?
|
| Databases, Factual | 2 | 2023 | 657 | 0.070 |
Why?
|
| Incidence | 3 | 2019 | 1006 | 0.070 |
Why?
|
| Likelihood Functions | 1 | 2005 | 54 | 0.060 |
Why?
|
| Social Justice | 1 | 2005 | 24 | 0.060 |
Why?
|
| Time Factors | 3 | 2018 | 2922 | 0.060 |
Why?
|
| Total Quality Management | 1 | 2004 | 23 | 0.060 |
Why?
|
| Medical Records Systems, Computerized | 1 | 2004 | 38 | 0.060 |
Why?
|
| Nursing Assessment | 1 | 2004 | 54 | 0.060 |
Why?
|
| Probability | 1 | 2004 | 164 | 0.060 |
Why?
|
| Narcotic Antagonists | 1 | 2024 | 134 | 0.060 |
Why?
|
| Oregon | 1 | 2023 | 13 | 0.060 |
Why?
|
| Risperidone | 1 | 2003 | 25 | 0.050 |
Why?
|
| Controlled Substances | 1 | 2022 | 7 | 0.050 |
Why?
|
| Chlorpromazine | 1 | 2002 | 15 | 0.050 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2008 | 486 | 0.050 |
Why?
|
| Accidents | 1 | 2021 | 21 | 0.050 |
Why?
|
| Pilot Projects | 1 | 2004 | 697 | 0.050 |
Why?
|
| Evidence-Based Medicine | 1 | 2002 | 247 | 0.050 |
Why?
|
| Research Design | 1 | 2003 | 342 | 0.050 |
Why?
|
| Socioeconomic Factors | 2 | 2015 | 579 | 0.040 |
Why?
|
| Program Evaluation | 1 | 2021 | 354 | 0.040 |
Why?
|
| Alcohol Drinking | 1 | 2020 | 226 | 0.040 |
Why?
|
| Quality of Health Care | 1 | 2020 | 187 | 0.040 |
Why?
|
| Poverty | 1 | 2020 | 199 | 0.040 |
Why?
|
| Self Report | 1 | 2019 | 199 | 0.040 |
Why?
|
| Hawaii | 1 | 2018 | 119 | 0.040 |
Why?
|
| Income | 1 | 2018 | 99 | 0.040 |
Why?
|
| Drug Interactions | 1 | 2018 | 208 | 0.040 |
Why?
|
| Choice Behavior | 1 | 2018 | 85 | 0.040 |
Why?
|
| Mortality | 1 | 2017 | 100 | 0.040 |
Why?
|
| Diagnosis, Dual (Psychiatry) | 1 | 2016 | 41 | 0.030 |
Why?
|
| Health Status | 1 | 2018 | 296 | 0.030 |
Why?
|
| Age Factors | 1 | 2019 | 1092 | 0.030 |
Why?
|
| Bayes Theorem | 1 | 2015 | 109 | 0.030 |
Why?
|
| Linear Models | 1 | 2015 | 278 | 0.030 |
Why?
|
| Videoconferencing | 1 | 2015 | 37 | 0.030 |
Why?
|
| Interdisciplinary Communication | 1 | 2015 | 55 | 0.030 |
Why?
|
| Quality of Life | 1 | 2020 | 839 | 0.030 |
Why?
|
| Psychotropic Drugs | 1 | 2015 | 77 | 0.030 |
Why?
|
| Schools, Medical | 1 | 2014 | 70 | 0.030 |
Why?
|
| Multivariate Analysis | 1 | 2015 | 581 | 0.030 |
Why?
|
| Interviews as Topic | 1 | 2015 | 259 | 0.030 |
Why?
|
| ROC Curve | 1 | 2014 | 232 | 0.030 |
Why?
|
| Medically Underserved Area | 1 | 2013 | 42 | 0.030 |
Why?
|
| Lipids | 1 | 2013 | 148 | 0.030 |
Why?
|
| Remission Induction | 1 | 2013 | 207 | 0.030 |
Why?
|
| Acetaminophen | 1 | 2015 | 283 | 0.030 |
Why?
|
| Korean War | 1 | 2011 | 4 | 0.020 |
Why?
|
| World War II | 1 | 2011 | 11 | 0.020 |
Why?
|
| Blood Pressure | 1 | 2013 | 524 | 0.020 |
Why?
|
| Blood Glucose | 1 | 2013 | 435 | 0.020 |
Why?
|
| Body Mass Index | 1 | 2013 | 656 | 0.020 |
Why?
|
| Diabetes Mellitus | 1 | 2013 | 286 | 0.020 |
Why?
|
| Calibration | 1 | 2009 | 58 | 0.020 |
Why?
|
| International Classification of Diseases | 1 | 2009 | 64 | 0.020 |
Why?
|
| Neuropsychological Tests | 1 | 2011 | 355 | 0.020 |
Why?
|
| Reference Values | 1 | 2009 | 310 | 0.020 |
Why?
|
| Forecasting | 1 | 2009 | 150 | 0.020 |
Why?
|
| Health Care Surveys | 1 | 2008 | 172 | 0.020 |
Why?
|
| Sickness Impact Profile | 1 | 2007 | 28 | 0.020 |
Why?
|
| Psychological Tests | 1 | 2007 | 50 | 0.020 |
Why?
|
| Geography | 1 | 2007 | 60 | 0.020 |
Why?
|
| Psychology | 1 | 2007 | 25 | 0.020 |
Why?
|
| Sex Distribution | 1 | 2007 | 133 | 0.020 |
Why?
|
| Veterans Disability Claims | 1 | 2006 | 3 | 0.020 |
Why?
|
| Continuity of Patient Care | 1 | 2007 | 53 | 0.020 |
Why?
|
| California | 1 | 2006 | 87 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2008 | 905 | 0.020 |
Why?
|
| Medicare | 1 | 2006 | 249 | 0.010 |
Why?
|
| Benchmarking | 1 | 2004 | 61 | 0.010 |
Why?
|
| Medication Systems, Hospital | 1 | 2002 | 5 | 0.010 |
Why?
|
| Hospitals, State | 1 | 2002 | 10 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2008 | 2379 | 0.010 |
Why?
|
| Southeastern United States | 1 | 2002 | 46 | 0.010 |
Why?
|
| Double-Blind Method | 1 | 2002 | 688 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2002 | 863 | 0.010 |
Why?
|
| Patient Discharge | 1 | 2002 | 319 | 0.010 |
Why?
|
| Neoplasms | 1 | 2007 | 1249 | 0.010 |
Why?
|
| Animals | 1 | 2011 | 13246 | 0.010 |
Why?
|